Net loss was $32,300,000 or $0.97 per share and $30,200,000 or 1 $0.30 per share for the 1st quarters of 2024 and 2023, respectively. As of March 31, 2024, we had $164,500,000 in cash, cash equivalents and marketable securities. During the Q1, we utilized our ATM facility for gross proceeds of approximately $56,000,000 Today, we are reiterating our full year 2024 net product revenues guidance from Germytel to be in the range of $95,000,000 to $102,000,000 We expect full year 2024 operating expenses in the range of $175,000,000 to $185,000,000 including non cash share based compensation expense of $6,000,000 to $11,000,000 subject to market conditions. The anticipated full year 2024 non cash financing expense related to the prepaid obligation to RTW Investments are expected to be in the range of $21,000,000 to $26,000,000 Of this amount, approximately $12,400,000 to $13,300,000 is expected to be in cash. For further details of our financials, please refer to our quarterly report on Form 10Q, which has been filed with the SEC.